Saturday, November 12, 2016 1:42:00 PM
Very good article giving insight on recent moves in EBIO... without explaining what a 30 minute candle is (;
http://oracledispatch.com/2016/11/10/eleven-biotherapeutics-inc-nasdaqebio-bull-run/
Hold long, hold strong. It's no secret management here is exploring options to maximize shareholder value.. Considering they are the largest stake holders. They have stated in PR exploring sale of company. Current CEO has sold companies before phase 3 results for a tasty premium and that's where EBIO is set up right now.
Recent SESN News
- Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights • PR Newswire (US) • 08/10/2023 11:30:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM